BKYI earnings / call / takeaways
BKYI Q3 FY26 earnings call: key takeaways
What BKYI said on its earnings call of November 13, 2026: results against expectations, what changed since last quarter, guidance and the questions analysts pressed on.
By Lician·November 13, 2026·AI-generated from the call transcript and Lician data
Results vs expectations
| Metric | Consensus | Reported | Result |
|---|---|---|---|
| EPS | -$0.35 | – | – |
| Revenue | $2.4M | – | – |
What changed since last quarter
- The company raised its outlook for 2027, citing a strong pipeline of regulated industry opportunities and recent wins in the Middle East and Europe. (30:50)
- BioKey confirmed that a large hardware order was delayed, impacting Q3 revenue, but expects it to be recognized over the next year. (28:32)
- The CEO expressed confidence in achieving profitability and cash flow positivity in 2027, supported by recurring license revenue and new business wins. (38:30)
What analysts pressed on
- Whether the delayed hardware order will impact cash flow and revenue in the near term. (28:32)
- How the company plans to scale its U.S. business and compete with larger players in the gaming and hospitality sector. (32:50)
- Concerns about the impact of short-term trading volatility and short interest on stock price. (54:20)
In their words
We expect roughly $1.2 million in annual license fee renewals in the first quarter alone.
Michael Depasquale (20:31)
Read the full transcript with the AI summary, or listen on the company's official webcast.
Every past call in full and transcript search come with Lician Pro.
Written by AI from the automatic transcript of the company's public webcast and Lician's earnings data. Each sentence cites the passage it comes from, and a sentence with a figure that is not in its sources was removed. Not investment advice.